Discovery of an Allosteric Agonist for Schizophrenia Risk Gene GPR52 with Antipsychotic Activity

被引：0
|
作者：
Murphy, Ryan E. [1 ]
Felsing, Daniel E. [1 ]
Dvorak, Nolan M. [1 ]
Laezza, Fernanda [1 ]
Cunningham, Kathryn A. [1 ]
Allen, John A. [1 ]
机构：
[1] Univ Texas Med Branch, Houston, TX USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.278870
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
537
引用
收藏
页数：1
相关论文
共 47 条
  • [41] Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and in vitro hepatic lipid homeostasis gene expression
    Wu, Tien-Yuan
    Tien, Ni
    Lin, Cheng-Li
    Cheah, Yu-Cun
    Hsu, Chung Y.
    Tsai, Fuu-Jen
    Fang, Yi-Jen
    Lim, Yun-Ping
    FRONTIERS IN MEDICINE, 2023, 10
  • [42] Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia
    Wang, Dong-Fang
    Cao, Bing
    Xu, Mei-Yan
    Liu, Ya-Qiong
    Yan, Lai-Lai
    Liu, Rong
    Wang, Jing-Yu
    Lu, Qing-Bin
    MEDICINE, 2015, 94 (36)
  • [43] Association of antipsychotic drugs on type 2 diabetes mellitus risk in patients with schizophrenia: a population-based cohort and in vitro glucose homeostasis-related gene expression study
    Fang, Yi-Jen
    Lee, Wan-Yi
    Lin, Cheng-Li
    Cheah, Yu-Cun
    Hsieh, Hui-Hsia
    Chen, Chi-Hua
    Tsai, Fuu-Jen
    Tien, Ni
    Lim, Yun-Ping
    BMC PSYCHIATRY, 2024, 24 (01)
  • [44] Loss-of-function variants in the schizophrenia risk gene SETD1A alter neuronal network activity in human neurons through the cAMP/PKA pathway
    Wang, Shan
    van Rhijn, Jon-Ruben
    Akkouh, Ibrahim
    Kogo, Naoki
    Maas, Nadine
    Bleeck, Anna
    Ortiz, Irene Santisteban
    Lewerissa, Elly
    Wu, Ka Man
    Schoenmaker, Chantal
    Djurovic, Srdjan
    van Bokhoven, Hans
    Kleefstra, Tjitske
    Kasri, Nael Nadif
    Schubert, Dirk
    CELL REPORTS, 2022, 39 (05):
  • [45] Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers
    Vaswani, Rishi G.
    Huang, David S.
    Anthony, Neville
    Xu, Lan
    Centore, Richard
    Schiller, Shawn
    Li, Zhifang
    Fan, Hong
    Setser, Jeremy
    Zawadzke, Laura E.
    Davenport, Yunji
    Chen, Xueying
    Barnash, Kimberly
    Adam, Ammar
    Ichikawa, Kana
    Huang, Liyue
    Gu, Chong-Hui
    Voigt, Johannes
    Millan, David
    Chan, Ho Man
    Decicco, Carl
    Hentemann, Martin
    Bellon, Steven F.
    Wilson, Kevin J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1772 - 1792
  • [46] Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia:: Synthesis and structure-activity relationship
    Wishka, Donn G.
    Walker, Daniel P.
    Yates, Karen M.
    Reitz, Steven C.
    Jia, Shaojuan
    Myers, Jason K.
    Olson, Kirk L.
    Jacobsen, E. Jon
    Wolfe, Mark L.
    Groppi, Vincent E.
    Hanchar, Alexander J.
    Thornburgh, Bruce A.
    Cortes-Burgos, Luz A.
    Wong, Erik H. F.
    Staton, Brian A.
    Raub, Thomas J.
    Higdon, Nicole R.
    Wall, Theron M.
    Hurst, Raymond S.
    Walters, Rodney R.
    Hoffmann, William E.
    Hajos, Mihaly
    Franklin, Stanley
    Carey, Galen
    Gold, Lisa H.
    Cook, Karen K.
    Sands, Steven B.
    Zhao, Sabrina X.
    Soglia, John R.
    Kalgutkar, Amit S.
    Arneric, Stephen P.
    Rogers, Bruce N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4425 - 4436
  • [47] Discovery of 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Integrated Drug-Design and Structure-Activity Relationships for Orally Potent, Metabolically Stable and Potential-Risk Reduced Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug
    Hayashi, Shigeo
    Hirao, Akiko
    Nakamura, Hiroshi
    Yamamura, Kenzo
    Mizuno, Kunihiko
    Yamashita, Hiroyo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 74 (04) : 369 - 381
12345